Research
The CRCI²NA is a multi-team research structure led by a director and a deputy director. Since January 2022, the laboratory is composed of twelve research teams under the responsibility of one or two researchers or teacher-researchers.
The objectives of the CRCI²NA are to looking at, understand and treat human cancerous pathologies. To this end, each team studies one or more components of tumours, which they understand as a cellular ecosystem whose establishment and evolution are governed by the communications exchanged.
To do this, the teams deploy a wide range of scientific, technical and technological skills which define the CRCI²NA as a multidisciplinary site, mainly under the responsibility of the ITMO Cancer but also of the ITMO I3M and Technologies for Health.
To do this, the teams deploy a wide range of scientific, technical and technological skills which define the CRCI²NA as a multidisciplinary site, mainly under the responsibility of the ITMO Cancer but also of the ITMO I3M and Technologies for Health.
- Immunomodulation of tumor microenvironment and immunotherapy of thoracic cancers - Team 1
- Nuclear Oncology - Team 2
- Innate Immunity and Cancer - Team 4
- Design and application of innovative loco-regional Treamtents in Gliobastoma - Team 5
- Signaling in Oncogenesis, Angiogenesis and Permeability - Team 6
- Stress Adaptation and Tumor Escape - Team 7
- Evicat Team 7 bis
- Integrative Cancer Genomics - Team 8
- Chromatin and Transriptional deregulation in pediatric bone sarcoma - Team 9
- Plasticity of Ecosystem from the Tumor after Radiotherapy - Team 10
- Molecular Vulnerabilities of tumor escape in mature B-cell malignancies - Team 11
- Manipulation of lymphocytes for Immunotherapy - Team 12
Mis à jour le 19 March 2024.